Form EFFECT Pasithea Therapeutics
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 27, 2026 |
| Accession Number: | 0001213900-26-007469 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics
- Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: Signs New FF Par Agreement with a Leading U.S. Robotics Distributor and Provides Details on FF EAI Robotics “Built in USA�
- Antengene Announces 2026 Interim Results: Achieves First‑Ever Profitability and Accelerates Value Creation Through Innovative R&D
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
